Cargando…
Newborn Screening for CAH—Challenges and Opportunities
Autores principales: | Heather, Natasha L., Nordenstrom, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006248/ https://www.ncbi.nlm.nih.gov/pubmed/33668620 http://dx.doi.org/10.3390/ijns7010011 |
Ejemplares similares
-
CAH Newborn Screening in India: Challenges and Opportunities
por: Dabas, Aashima, et al.
Publicado: (2020) -
Measurement of 17-Hydroxyprogesterone by LCMSMS Improves Newborn Screening for CAH Due to 21-Hydroxylase Deficiency in New Zealand
por: de Hora, Mark R., et al.
Publicado: (2020) -
Diagnosis and prevalence of Congenital Adrenal Hyperplasia (CAH) in Austrian children screened or not screened for CAH
por: Luxenberger, Katharina, et al.
Publicado: (2013) -
Thirty-Year Lessons from the Newborn Screening for Congenital Adrenal Hyperplasia (CAH) in Japan
por: Tsuji-Hosokawa, Atsumi, et al.
Publicado: (2021) -
Perturbed Beta-Cell Function and Lipid Profile After Early Prenatal Dexamethasone Exposure in Individuals Without CAH
por: Wallensteen, Lena, et al.
Publicado: (2020)